hyperuremic pruritus. Pruritus, unspecified
Conditions
Interventions
Intervention 1: Control group: Placebo, two times a day for two months. Intervention 2: Intervention group: Sambucus ebulus topical preparation 2% , two times a day for two months.
Placebo
Treatment - Drugs
Control group: Placebo, two times a day for two months
Intervention group: Sambucus ebulus topical preparation 2% , two times a day for two months
Sponsors
Vice chancellor for research, Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Patients with hemodialysis during 3 months, or chronic renal failure with hyperuremia; at the age of 18 years and more; 3 times pruritus during last two weeks before study; dry skin without edema. Exclusion criteria: Other diseases like liver failure and heart disease; pregnancy and breast feeding; sensitivity to topical preparation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pruritus severity. Timepoint: Baseline, 4th and 8th week. Method of measurement: Pruritus severity scale (48 scores). | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin Xerosis. Timepoint: Baseline, 4th and 8th weeks. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Saeedi
Mazandaran University of Medical Sciences
Outcome results
None listed